Background

• The time from ordering an oral oncolytic to patient receipt of product can be a source of angst for both patient and prescriber hoping to avoid delays in treatment. Previous studies report a median time to access oral oncolytics ranging between four to twelve days.The factors that contribute to the lag between prescription writing and patient access include prior authorizations, financial toxicity, pharmacy review, and delivery time.
• Health System Specialty Pharmacies (HSSPs) are uniquely positioned to overcome these barriers. Parkview Health established an integrated specialty pharmacy service to streamline and improve the process for patients in need of oral oncolytics.

Objectives

To compare the time to access oral oncolytic treatments before and after health system specialty pharmacy integration. Access time being defined as the difference in business days between a new order and patient receipt of the ordered product.

Read the Outcomes Study by submitting the form below.

​